|
Status |
Public on Jul 06, 2018 |
Title |
AHR ChIP-seq in lymphoblastoid cell line |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
ChIP-seq was done on one lymphoblastoid cell lines for vehicle control, or 3-MC agonist treatment to identify AHR binding regions throughout the genome. We identified 17,688 common binding peaks between all ChIP treatments
|
|
|
Overall design |
A lymphoblastoid cell line was treated in duplicate with vehicle control or 1uM 3-MC 24 hours before cells were collected for ChIP-seq. Sequencing was carried out on Illumina HiSeq 4000
|
|
|
Contributor(s) |
Weinshlboum RM, Neavin DR, Lee J, Ye Z, Wang L |
Citation(s) |
31292129 |
|
Submission date |
Jul 05, 2018 |
Last update date |
May 12, 2020 |
Contact name |
Drew Neavin |
E-mail(s) |
d.neavin@garvan.org.au
|
Organization name |
Garvan Institute of Medical Research
|
Department |
Cellular Science
|
Street address |
384 Victoria St
|
City |
Darlinghurst |
State/province |
New South Wales |
ZIP/Postal code |
2010 |
Country |
Australia |
|
|
Platforms (1) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (6)
|
|
This SubSeries is part of SuperSeries: |
GSE116638 |
Role of AHR in lymphoblastoid cell lines |
|
Relations |
BioProject |
PRJNA479757 |
SRA |
SRP152200 |